By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



11 rue de MOLSHEIM, 67082
Cedex      France
Phone: 011-33-3-88-27-91-21 Fax: 011-33-3-88-27-91-11



Gene Therapy


Human Genome Sciences, Inc.  Gene Therapy Partnerships

Company News
PharmaVentures Ltd Advises TRANSGENE (ENX:TNG) On The Sale Of Their Biopharmaceutical Manufacturing Plant 2/4/2016 11:15:40 AM
TRANSGENE (ENX:TNG) And ABL Announce The Acquisition By ABL Europe Of Transgene’s Production Asset 2/3/2016 10:36:54 AM
EIB Lends EUR 20m To TRANSGENE (ENX:TNG) 1/28/2016 10:22:37 AM
TRANSGENE (ENX:TNG) Announces Financial Calendar For 2016 1/8/2016 9:28:48 AM
After Restructuring in 2015, TRANSGENE (ENX:TNG) Enters New Phase in Its Strategic Development 1/7/2016 6:04:53 AM
TRANSGENE (ENX:TNG) Announces First Patient Randomized In Multinational Phase 3 Trial For Pexa-Vec Oncolytic Immunotherapy In Advanced Liver Cancer 1/6/2016 10:15:49 AM
TRANSGENE (ENX:TNG) Announces Publication In "The Lancet Oncology" Of Phase 2b TIME Trial Results With TG4010 Immunotherapy In Non-Small Cell Lung Cancer 12/23/2015 12:45:07 PM
TRANSGENE (ENX:TNG) And SillaJen Announce Revised Agreement For Pexa-Vec Oncolytic Viral Therapy And Provide Update On Clinical Development 11/12/2015 12:23:04 PM
TRANSGENE (ENX:TNG) Announces Dosing Of First Patient With TG1050 For Treatment Of Chronic Hepatitis B Infection 11/4/2015 10:24:16 AM
TRANSGENE (ENX:TNG) Reports Third Quarter 2015 Financial Results 10/21/2015 10:17:52 AM